Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 65

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

The emerging threat of superwarfarins: history, detection, mechanisms, and countermeasures

Feinstein, Douglas L., Akpa, Belinda S., Ayee, Manuela A., Boullerne, Anne I., Braun, David, Brodsky, Sergey V., Gidalevitz, David, Hauck, Zane, Kalinin, Sergey, Kowal, Kathy, Kuzmenko, Ivan, Lis, Kinga, Marangoni, Natalia, Martynowycz, Michael W., Rubinstein, Israel, van Breemen, Richard, Ware, Kyle, Weinberg, Guy · 2016 · Annals of the New York Academy of Sciences

Abstract

Superwarfarins were developed following the emergence of warfarin resistance in rodents. Compared to warfarin, superwarfarins have much longer half‐lives and stronger affinity to vitamin K epoxide reductase and therefore can cause death in warfarin‐resistant rodents. By the mid‐1970s, the superwarfarins brodifacoum and difenacoum were the most widely used rodenticides throughout the world. Unfortunately, increased use was accompanied by a rise in accidental poisonings, reaching >16,000 per year in the United States. Risk of exposure has become a concern since large quantities, up to hundreds of kilograms of rodent bait, are applied by aerial dispersion over regions with rodent infestations. Reports of intentional use of superwarfarins in civilian and military scenarios raise the specter of larger incidents or mass casualties. Unlike warfarin overdose, for which 1–2 days of treatment with vitamin K is effective, treatment of superwarfarin poisoning with vitamin K is limited by extremely high cost and can require daily treatment for a year or longer. Furthermore, superwarfarins have actions that are independent of their anticoagulant effects, including both vitamin K–dependent and –independent effects, which are not mitigated by vitamin K therapy. In this review, we summarize superwarfarin development, biology and pathophysiology, their threat as weapons, and possible therapeutic approaches.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/nyas.13085

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 81

  1. 10.1161/01.CIR.89.1.432 · DOI
  2. 10.1111/j.1365-2141.2008.07119.x · DOI · Paper page
  3. Stahman M.A., 1941, Studies on the hemorrhagic sweet clover disease: V. Identification and synthesis of the hemorrhagic agent, J. Biol. Chem, 138, 513, 10.1016/S0021-9258(18)51377-6 · doi:10.1016/s0021-9258(18)51377-6
  4. 10.1021/bi00601a003 · DOI · Paper page
  5. 10.1089/ars.2006.8.347 · doi:10.1089/ars.2006.8.347
  6. 10.1111/j.1538-7836.2005.01419.x · DOI · Paper page
  7. 10.2307/4587549 · doi:10.2307/4587549
  8. D'Ambrosio G., 1952, Warfarin as rodenticide, Riv. Ital. Ig, 12, 367
  9. 10.5482/HAMO-13-09-0047 · DOI
  10. 10.1038/nature02214 · DOI · Paper page
  11. 10.1038/253275a0 · doi:10.1038/253275a0
  12. 10.1017/S0022172400046969 · doi:10.1017/s0022172400046969
  13. 10.1017/S0022172400055807 · doi:10.1017/s0022172400055807
  14. 10.1172/JCI104839 · DOI · Paper page
  15. 10.1016/j.bmc.2007.01.014 · doi:10.1016/j.bmc.2007.01.014
  16. 10.1001/jama.1984.03350210052030 · doi:10.1001/jama.1984.03350210052030
  17. Watts R.G., 1990, Accidental poisoning with a superwarfarin compound (brodifacoum) in a child, Pediatrics, 86, 883
  18. 10.1016/S0140-6736(87)91876-9 · doi:10.1016/s0140-6736(87)91876-9
  19. 10.1016/j.tmrv.2015.06.002 · doi:10.1016/j.tmrv.2015.06.002
  20. 10.1016/j.ecoenv.2014.11.013 · doi:10.1016/j.ecoenv.2014.11.013
  21. 10.1007/s00128-005-0668-1 · doi:10.1007/s00128-005-0668-1
  22. 10.1007/s00128-011-0470-1 · doi:10.1007/s00128-011-0470-1
  23. 10.1002/ajh.20784 · doi:10.1002/ajh.20784
  24. Patocka J., 2013, Toxic potential of superwarfarin: brodifacoum, Mil. Med. Sci. Lett, 82, 9, 10.31482/mmsl.2013.003 · doi:10.31482/mmsl.2013.003
  25. Federal Bureau Investigation.2011. Arrest of suspect in connection with viable improvised explosive device found in Spokane Washington. Joint Intelligence Bulletin March 9 2011. Accessed April 8 2016.info.publicintelligence.net/FBI‐SpokaneIED.pdf.
  26. Brickhill J., 1992, Zimbabwe's poisoned legacy: secret war in Southern Africa, Covert Action, 43, 58
  27. Epstein P.R., 2011, Changing Planet, Changing Health: How the Climate Crisis Threatens Our Health and What We Can Do About It
  28. 10.1086/649403 · doi:10.1086/649403
  29. United Nations, 2003, Project coast: apartheid's chemical and biological warfare programme
  30. Gould C., 2002, Secrets and Lies: Wouter Basson and South Africa's Chemical and Biological Warfare Programme
  31. 10.1517/17425255.2011.576247 · doi:10.1517/17425255.2011.576247
  32. 10.1007/BF01839210 · doi:10.1007/bf01839210
  33. 10.1016/S0021-9673(00)89327-9 · doi:10.1016/s0021-9673(00)89327-9
  34. Benchev I., 1990, [Derivative spectroscopy and its use in sanitary hygiene control], Probl. Khig, 15, 102
  35. 10.1159/000137881 · DOI
  36. 10.1093/jat/15.3.144 · doi:10.1093/jat/15.3.144
  37. 10.1016/j.forsciint.2012.07.008 · doi:10.1016/j.forsciint.2012.07.008
  38. 10.1093/jat/34.5.273 · DOI
  39. 10.1007/s00216-015-8954-1 · doi:10.1007/s00216-015-8954-1
  40. 10.1016/j.forsciint.2011.08.003 · doi:10.1016/j.forsciint.2011.08.003
  41. 10.1093/jat/bkw008 · doi:10.1093/jat/bkw008
  42. 10.1007/s00774-015-0734-7 · DOI
  43. 10.1016/j.molmed.2012.12.008 · DOI · Paper page
  44. 10.1002/jcp.24838 · DOI
  45. 10.1016/S0083-6729(07)00010-6 · DOI
  46. 10.3945/an.111.001784 · DOI · Paper page
  47. 10.1007/s12035-008-8022-3 · DOI · Paper page
  48. Sundaram K.S., 1988, Warfarin administration reduces synthesis of sulfatides and other sphingolipids in mouse brain, J. Lipid Res, 29, 1475, 10.1016/S0022-2275(20)38426-1 · doi:10.1016/s0022-2275(20)38426-1
  49. 10.1016/j.jnutbio.2009.09.005 · DOI
  50. 10.1002/1096-9861(20000918)425:2<295::AID-CNE11>3.0.CO;2-G · DOI
  51. 10.2741/4390 · doi:10.2741/4390
  52. Kahn R.A., 1971, Effects of sodium warfarin on capillary ultrastructure, Am. J. Pathol, 65, 149
  53. Leithauser B., 2009, Capillary bleeding under oral anticoagulation, Clin. Hemorheol. Microcirc, 43, 167, 10.3233/CH-2009-1231 · doi:10.3233/ch-2009-1231
  54. 10.1053/j.ajkd.2009.04.024 · DOI · Paper page
  55. 10.1159/000312877 · doi:10.1159/000312877
  56. 10.1681/ASN.2010101110 · doi:10.1681/asn.2010101110
  57. 10.1159/000337918 · DOI
  58. 10.1159/000433568 · doi:10.1159/000433568
  59. 10.1152/ajprenal.00689.2012 · DOI
  60. 10.1016/j.fct.2012.01.049 · DOI
  61. 10.1021/jp400264x · doi:10.1021/jp400264x
  62. 10.1007/s11095-010-0150-6 · DOI
  63. 10.1073/pnas.84.12.4089 · DOI · Paper page
  64. 10.1016/j.jcis.2016.01.056 · DOI
  65. 10.1016/S0268-960X(98)90020-0 · doi:10.1016/s0268-960x(98)90020-0
  66. 10.1080/15563650701354093 · doi:10.1080/15563650701354093
  67. 10.1016/S0140-6736(05)70808-4 · doi:10.1016/s0140-6736(05)70808-4
  68. 10.1067/mem.2000.108317 · doi:10.1067/mem.2000.108317
  69. 10.1001/archinte.1993.00410160099010 · DOI
  70. Weitzel J.N., 1990, Surreptitious ingestion of a long‐acting vitamin K antagonist/rodenticide, brodifacoum: clinical and metabolic studies of three cases, Blood, 76, 2555, 10.1182/blood.V76.12.2555.2555 · doi:10.1182/blood.v76.12.2555.2555
  71. 10.3109/15563650.2011.587126 · doi:10.3109/15563650.2011.587126
  72. 10.2146/ajhp130537 · doi:10.2146/ajhp130537
  73. 10.1177/0148607115595979 · DOI
  74. 10.1097/AAP.0b013e3181d22fcd · doi:10.1097/aap.0b013e3181d22fcd
  75. 10.1016/j.jconrel.2014.11.018 · DOI
  76. 10.1097/CCM.0b013e318287f874 · DOI
  77. 10.1177/0148607193017002142 · doi:10.1177/0148607193017002142
  78. 10.1093/ajcn/67.4.716 · doi:10.1093/ajcn/67.4.716
  79. Medić B., 2016, Evaluation of novel biomarkers of acute kidney injury: the possibilities and limitations, Curr. Med. Chem
  80. United States Environmental Protection Agency, 1981, Warfarin and its sodium salt: pesticide registration standard
  81. 10.1016/j.bpj.2016.03.004 · doi:10.1016/j.bpj.2016.03.004

Cited by

Metadata

Authors
Feinstein, D. L., Akpa, B. S., Ayee, M. A., Boullerne, A. I., Braun, D., Brodsky, S. V., Gidalevitz, D., Hauck, Z., Kalinin, S., Kowal, K., Kuzmenko, I., Lis, K., Marangoni, N., Martynowycz, M. W., Rubinstein, I., van Breemen, R., Ware, K., & Weinberg, G.
Affiliations
  • Department of Anesthesiology University of Illinois Chicago Illinois
  • Department of Molecular Biomedical Sciences North Carolina State University Raleigh North Carolina
  • Department of Medicine University of Illinois Chicago Illinois
  • Department of Pathology the Ohio State University Columbus Ohio
  • Department of Physics and the Center for the Molecular Study of Condensed Soft Matter Illinois Institute of Technology Chicago Illinois
  • Department of Medicinal Chemistry and Pharmacognosy University of Illinois Chicago Illinois
  • X‐ray Science Division Argonne National Laboratory Lemont Illinois
Venue
Annals of the New York Academy of Sciences
Publisher
Wiley
Published
2016-05-31
Volume
1374
Issue
1
Pages
111-122
ISSN
  • 0077-8923
  • 1749-6632
Cited by
65
References
1
Language
en
Funders
National Institutes of Health (U01NS083457)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.